Evidence map›Paper›PMID 42446084›Full record

ReviewChembiochem : a European journal of chemical biology2026

Enzyme-Inspired Design of Redox-Active Molecules for Promotion of Oxidative Protein Folding.

Keita Mori, Takahiro Muraoka

Abstract readReview
In one paragraph

Review in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Keita MoriDepartment of Applied Chemistry, Graduate School of Engineering, Tokyo University of Agriculture and Technology, Koganei, Tokyo, Japan.
Takahiro MuraokaDepartment of Applied Chemistry, Graduate School of Engineering, Tokyo University of Agriculture and Technology, Koganei, Tokyo, Japan.ORCID https://orcid.org/0000-0001-6744-048X

Funding

Japan Science and Technology Agency JPMJAP2526Japan Science and Technology Agency JPMJFR2122Japan Society for the Promotion of Science JP23KJ0851Japan Society for the Promotion of Science JP25K01891
6 · The paper itself

Abstract

Protein folding is essential for maturation of nascent polypeptides into native proteins. In living cells, molecular chaperones and enzymes efficiently and synergistically promote protein folding. Inspired by biological folding systems, researchers have developed synthetic chemical chaperones for promoting protein folding in vitro. Many secretory proteins have multiple disulfide (SS) bonds, and therefore, their folding reactions are intrinsically an oxidative process, namely, oxidative folding. This review highlights representative strategies in the design of redox-active compounds that promote oxidative protein folding. Small-molecule thiols and disulfides were developed for oxidative folding promotion, which have been improved by optimizing their molecular structures and reactivities. The chemical features of natural folding enzymes have also inspired researchers to develop folding promoters that reproduce the structural and chemical features of the enzymes. Biological contexts have been considered recently, giving birth to stress-responsive folding promoters. These efforts described herein would pave the way for the development of novel synthetic reagents that enhance industrial protein production processes and prevent protein misfolding diseases.

Indexed as

EnzymesProtein FoldingSulfhydryl CompoundsDisulfidesHumansMolecular ChaperonesOxidation-ReductionDisulfidesEnzymesMolecular ChaperonesSulfhydryl Compoundsbioorganic chemistrychaperone proteinsenzyme modelsprotein foldingredox chemistry

Identifiers

PMID42446084
PMCPMC13367030

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.